Novo Nordisk adapts Rybelsus launch to the coronavirus era
Novo Nordisk integrated COVID-19 education into its launch strategy for diabetes treatment Rybelsus.
Most recent articles by Alison Kanski
Watch: EmpowHER demonstrates racial bias in healthcare with voice actor
The video shows how white and Black patients could receive different treatment because of unconscious bias.
Campaign: Bristol Myers Squibb shows life after cancer in video series
The series, Survivorship Today, features actor Sterling K. Brown interviewing cancer survivors.
The Escalator: BW Health Group names New England lead
Plus people moves at Ro and AveXis.
Five things for pharma marketers to know: Thursday, July 2, 2020
Pfizer, BioNTech coronavirus vaccine shows promise; Sherlock Biosciences to bring CRISPR COVID-19 test to doctor’s offices; Submit a cover design for MM&M’s Hall of Femme issue.
Five things for pharma marketers to know: Wednesday, July 1, 2020
FDA outlines conditions to approve coronavirus vaccine; Fauci warns daily COVID-19 cases could more than double in U.S.; Join the MM&M Move Together event.
Five things for pharma marketers to know: Tuesday, June 30, 2020
Gilead announces price for remdesivir; Bipartisan support of drug price legislation has waned; More states slow down reopening as COVID-19 cases rise.
Gilead names remdesivir price
The treatment will cost $3,120 for a five-day treatment course for a patient with private insurance in the U.S.
Five things for pharma marketers to know: Monday, June 29, 2020
Justice Department asks Supreme Court to overturn ACA; States reverse reopening as virus cases climb; Submit creative to MM&M’s #CreateHealthEquity initiative.
Cannes Lions Live: Marketing in a time of racial justice and a pandemic
Leaders discussed how agencies can evolve in light of the movement for racial justice and the COVID-19 pandemic.
